Plain-English translation of NCT07515989 on ClinicalTrials.gov ↗ ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new diagnostic approach for leprosy that combines ultrasound imaging with a minimally invasive tissue sample collection. Researchers will collect a small sample of tissue near an affected nerve using ultrasound guidance, then use advanced laboratory tests to detect leprosy bacteria DNA and RNA. This approach aims to improve early diagnosis and help doctors determine whether treatment has successfully cured the infection.
Current methods for diagnosing leprosy have important limitations—they often miss cases, especially early-stage disease—and there is no reliable way to confirm that someone is truly cured after treatment. This new sampling method could provide a more accurate, less invasive way to detect the bacteria and monitor whether treatment is working.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have a clinical examination and an ultrasound scan of your nerves. A doctor will then use ultrasound guidance to collect a small tissue sample from the area around your ulnar nerve—this is similar to having blood drawn, but from tissue rather than a vein. Your sample will be sent to the laboratory for molecular testing to detect leprosy bacteria. The entire process is minimally invasive and designed to avoid damaging the nerve itself.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Brazil